ClinicalTrials.gov
ClinicalTrials.gov Menu

DoD-NCI TRICARE Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02339025
Recruitment Status : Not yet recruiting
First Posted : January 15, 2015
Last Update Posted : August 9, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

Brief Summary:

Background:

- Researchers at the National Cancer Institute and the Department of Defense are trying to learn more about what causes cancer, heart disease, and other health problems. To do this, they gather data on risk factors and biological markers. They get these data from large groups of people in long-running studies. As these groups of people age, researchers must form new groups. TRICARE is a health insurance program for uniformed service members and their families. It is a major part of the Military Health System. Researchers hope to form a new study group from TRICARE members. This study will test if TRICARE members will take part in a research study.

Objectives:

- To test if TRICARE members will take part in a research study.

Eligibility:

- TRICARE members aged 35 74 with military primary care providers at Walter Reed National Military Medical Center. They must not have a prior diagnosis of cancer other than non-melanoma skin cancer.

Design:

  • Participants will fill out a survey. It will ask about their risk factors for cancer and other chronic diseases. Their medical records will be reviewed. They will give a blood sample.
  • If a larger study is formed, then participants data will be used in the larger study. They may be asked to give more samples.

Condition or disease
Cancer

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: The NCI-DoD TriCare Feasibility Study
Study Start Date : January 14, 2015
Estimated Primary Completion Date : September 22, 2020
Estimated Study Completion Date : September 20, 2021



Primary Outcome Measures :
  1. Participation rates [ Time Frame: End of study recruitment ]
  2. Data linkage [ Time Frame: Before study recruitment ]

Secondary Outcome Measures :
  1. Cross-sectional biomarker study [ Time Frame: End of study recruitment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years to 74 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Participants will be selected according to the MTF, gender, age, and race/ethnicity. Beneficiaries aged 35-74 years with military primary care providers at WRNMMC or FBCH or beneficiaries living in these catchment or service areas.

EXCLUSION CRITERIA:

Beneficiaries less than 35 years of age will be excluded because cancer incidence at these ages is low and therefore it is unlikely to be feasible from a cost/information perspective to include them. Beneficiaries 75 years of age or older will be excluded because it is unlikely they will have long-term follow-up.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02339025


Contacts
Contact: Catherine Schairer, Ph.D. (301) 435-3979 schairec@mail.nih.gov

Locations
United States, Maryland
Walter Reed National Medical Center Not yet recruiting
Bethesda, Maryland, United States, 20301
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Catherine Schairer, Ph.D. National Cancer Institute (NCI)

Responsible Party: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT02339025     History of Changes
Other Study ID Numbers: 999915062
15-C-N062
First Posted: January 15, 2015    Key Record Dates
Last Update Posted: August 9, 2018
Last Verified: July 31, 2018

Keywords provided by National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ):
Cohort
Participation
Biobank